fbpx Skip to content

Change the Future for Your Patients and Your Practice

Your patients will be impressed by the innovative technology of the headset. You and your team will appreciate how easily the AdaptDx Pro fits into your workflow. Everyone will welcome the peace of mind that comes from the early diagnosis and treatment of AMD.

Join the AMD Revolution


Customer Success Stories

Our collection of customer success stories offers a look at some of the benefits of integrating dark adaptation testing into your patient care arsenal. Learn how your fellow eye care professionals utilize AdaptDx® technology as they work towards improved outcomes for their AMD patients as well as their practice.


Practical Implementation of Dark Adaptation in Optometric Practice

E-Book: Practical Implementation of Dark Adaptation in Optometric Practice

Going beyond explaining why dark adaptation is so important in optometric practice. Having already established the reasons why functional testing is essential, this year’s report outlines the practical strategies for how to make routine testing a reality in your own eye care practice.


Read our Featured Blog

5 Tips for Recommending Smoking Cessation Programs

Dr. Timothy Earley shares tips on how to talk to patients about smoking cessation, the biggest modifiable risk factor for AMD, and how to motivate them to quit.

Macular degeneration

Tour our Virtual Exhibit

Our interactive Virtual Exhibit allows you to meet the newest member of our team – Theia, the on-board technician for the AdaptDx Pro headset dark adaptometer. Theia will welcome you to the booth as you learn how tackling AMD can benefit your practice.

Explore the exhibit at your leisure – without any sales pressure – and see this amazing technology for yourself. When you are ready to learn more, just enter your ZIP Code into the laptop in the booth to find your Regional Sales Executive.


Impaired Dark Adaptation: The Earliest Biomarker of AMD (video)

Before drusen are visible, an invisible layer of cholesterol builds up between the pigmented layer of the retina (RPE) and the elastic layer of Bruch’s membrane. These cholesterol deposits — basal laminar (BLamD) and basal linear (BLinD) — cause oxidative stress and inflammation, hindering nutrient transportation to photoreceptor cells. As photoreceptor cells die, it becomes harder for the eyes to adjust to the darkness, and night vision declines. This dark adaptation impairment is the first sign of AMD.

The cholesterol deposits grow over time. Where they become sufficiently thickened, the lesion becomes clinically detectable as a druse. The first visible druse caused by AMD is just the tip of the iceberg of these lesions.

Research has shown that impaired dark adaptation function can be detected at least three years before drusen are clinically evident, allowing for earlier diagnosis, treatment, and monitoring of AMD.


Frequently Asked Questions

Find the answers to frequently asked questions about AMD, dark adaptation, and AdaptDx Pro testing.

Partner with MacuLogix

Implementation Expertise

Each AdaptDx Pro® purchase is supported by our AMD Excellence Program®️ to help you achieve your patient care and practice revenue goals.

Contact Our Sales Team

As the AMD Experts®, our sales team is here to answer your questions about the clinical and financial benefits of the AdaptDx Pro.